GLPwatch
Trials (2036)
GLP-1 clinical trials from ClinicalTrials.gov, refreshed daily.
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
- Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
- A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
- ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
- Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
- Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
- Life Style Modification Medical and Surgical Management in Patients With Obesity
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
- Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
- Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
- A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
- Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
- Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
- Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
- A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
- Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
- Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
- The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
- Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
- Emulation of the SOUL Diabetes Trial in Healthcare Claims
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
- Effects of Obesity Treatments on Food Preferences and Metabolism
- The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
- Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
- A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
- A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
- Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
- The Effect of Semaglutide on the Intestinal Flora in Obesity
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Liraglutide and Cardio-Metabolic Risk Markers
- The Semaglutide Study
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
- Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
- A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
- Tirzepatide for Obesity and Meth Use Disorder
- A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
- Feasibility of Semaglutide in Advanced Lung Disease
- Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
- A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification